North America

The Lorazepam Prices in the United States mimic similar market sentiments as that of India. Until November, the prices inclined moderately on the back of consistent end-user demand from the domestic market balanced with the overall supplies among the market participants. However, as the year ended, the prices for Lorazepam dropped gradually in December 2022, which resulted in the stockpiling of inventories among the market players, propelling them to reduce their prices to destock their stockpiles and maintain their profit. Additionally, a decrease in shipping costs, slower consumer demand, and a temporary shutdown of the domestic market kept the price trend of Lorazepam on the weaker side.


Lorazepam prices witnessed a descending trend throughout the fourth quarter of 2022 in the Asia Pacific region. The prices inclined stably until November and dropped considerably following the last month of the fourth quarter. A slight increase in demand balanced with the stockpiled inventories among the market players kept the prices of Lorazepam on the sturdy side. Rising energy prices additionally impacted the market sentiments of all the sectors, including Pharmaceutical as manufacturing cost and the values of upstream material inclined until the mid of the final quarter of 2022. Later in December, the prices for Lorazepam dropped owing to bearish demand, which resulted in the overall storage of inventories. Overall, the price of Lorazepam noted at the end of the fourth quarter was assembled at USD 790141.93/MT Ex Ahmedabad in India.


During the fourth quarter of 2022, the European market for Lorazepam also followed a similar pattern to that of Asia Pacific. The market trend primarily began on a healthy note until November in Germany because of increased end-user demand from the pharmaceutical industry. Inquiries from the downstream sector for Lorazepam began to decrease significantly after November, i.e., with the start of December 2022, with enough supplies among the market participants. In addition to that, traders further cut back their placed orders to prevent further stockpiling.

ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst's primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.